RecruitingNot applicableNCT06427642

Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shandong Qilu Stem Cells Engineering Co., Ltd.
Principal Investigator
Xiaoying Li, MD
Qilu Children's Hospital of Shandong University
Intervention
Mononuclear cells(biological)
Enrollment
120 enrolled
Eligibility
All sexes
Timeline
20222025

Study locations (1)

Collaborators

Qilu Children's Hospital of Shandong University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06427642 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials